{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:20:45Z","timestamp":1780478445202,"version":"3.54.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Research Fund of Erzincan Binali Y\u0131ld\u0131r\u0131m University","award":["TSA-2020-729"],"award-info":[{"award-number":["TSA-2020-729"]}]},{"name":"Research Fund of Anadolu University","award":["2102S003"],"award-info":[{"award-number":["2102S003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11030-022-10422-8","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T09:02:24Z","timestamp":1649494944000},"page":"2825-2845","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif"],"prefix":"10.1007","volume":"26","author":[{"given":"\u00d6zcan","family":"G\u00fcle\u00e7","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-2789","authenticated-orcid":false,"given":"C\u00fcneyt","family":"T\u00fcrke\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0796-4374","authenticated-orcid":false,"given":"Mustafa","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeliz","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye\u015fim","family":"Yeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Hac\u0131m\u00fcft\u00fco\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erg\u00fcn","family":"Ereminsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer \u0130rfan","family":"K\u00fcfrevio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e\u00fckr\u00fc","family":"Beydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"key":"10422_CR1","volume-title":"Heterocyclic chemistry in drug discovery","author":"JJ Li","year":"2013","unstructured":"Li JJ (2013) Heterocyclic chemistry in drug discovery. John Wiley & Sons"},{"key":"10422_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2013.11.017","author":"AC Tripathi","year":"2014","unstructured":"Tripathi AC, Gupta SJ, Fatima GN, Sonar PK, Verma A, Saraf SK (2014) 4-Thiazolidinones: the advances continue\u2026. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2013.11.017","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10422_CR3","first-page":"763","volume":"71","author":"MA Bhat","year":"2014","unstructured":"Bhat MA (2014) Synthesis and anti-mycobacterial activity of new 4-thiazolidinone and 1,3,4-oxadiazole derivatives of isoniazid. Acta Pol Pharm 71(5):763\u2013770","journal-title":"Acta Pol Pharm"},{"key":"10422_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2016.12.008","author":"KA Szychowski","year":"2017","unstructured":"Szychowski KA, Leja ML, Kaminskyy DV, Binduga UE, Pinyazhko R, Lesyk RB et al (2017) Study of novel anticancer 4-thiazolidinone derivatives. Chem-Biol Interact. https:\/\/doi.org\/10.1016\/j.cbi.2016.12.008","journal-title":"Chem-Biol Interact"},{"key":"10422_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2017.02.007","author":"R Suryawanshi","year":"2017","unstructured":"Suryawanshi R, Jadhav S, Makwana N, Desai D, Chaturbhuj D, Sonawani A et al (2017) Evaluation of 4-thiazolidinone derivatives as potential reverse transcriptase inhibitors against HIV-1 drug resistant strains. Bioorg Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2017.02.007","journal-title":"Bioorg Chem"},{"issue":"3","key":"10422_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.arabjc.2010.10.032","volume":"7","author":"A Deep","year":"2014","unstructured":"Deep A, Jain S, Sharma PC, Mittal SK, Phogat P, Malhotra M (2014) Synthesis, characterization and antimicrobial evaluation of 2, 5-disubstituted-4-thiazolidinone derivatives. Arabian J Chem 7(3):287\u2013291. https:\/\/doi.org\/10.1016\/j.arabjc.2010.10.032","journal-title":"Arabian J Chem"},{"key":"10422_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2013.03.030","author":"A Kunzler","year":"2013","unstructured":"Kunzler A, Neuenfeldt PD, das Neves AM, Pereira CM, Marques GH, Nascente PS et al (2013) Synthesis, antifungal and cytotoxic activities of 2-aryl-3-((piperidin-1-yl) ethyl) thiazolidinones. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2013.03.030","journal-title":"Eur J Med Chem"},{"issue":"3","key":"10422_CR8","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.26452\/ijrps.v10i3.1477","volume":"10","author":"SH Derawey","year":"2019","unstructured":"Derawey SH, Mosa MN, Jasim EQ, Hraishawi RM (2019) Synthesis, characterization and antibacterial evaluation of 1,3,4-oxadiazole derivatives. Int J Res Pharm Sci 10(3):2342\u20132350","journal-title":"Int J Res Pharm Sci"},{"key":"10422_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s42250-019-00084-9","author":"SG Nayak","year":"2019","unstructured":"Nayak SG, Poojary B (2019) A review on the preparation of 1,3,4-oxadiazoles from the dehydration of hydrazines and study of their biological roles. Chem Afr. https:\/\/doi.org\/10.1007\/s42250-019-00084-9","journal-title":"Chem Afr"},{"issue":"2","key":"10422_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.30731\/ijcps.7.2.2018.13-26","volume":"7","author":"P Dholaria","year":"2018","unstructured":"Dholaria P, Parikh K, Joshi D, Joshi A (2018) Synthesis, characterization and antimicrobial screening of sulphonamide based 1, 3, 4-oxadiazoles. Int J Chem Phys Sci 7(2):13. https:\/\/doi.org\/10.30731\/ijcps.7.2.2018.13-26","journal-title":"Int J Chem Phys Sci"},{"issue":"5","key":"10422_CR11","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1021\/jm2013248","volume":"55","author":"J Bostr\u00f6m","year":"2012","unstructured":"Bostr\u00f6m J, Hogner A, Llin\u00e0s A, Wellner E, Plowright AT (2012) Oxadiazoles in medicinal chemistry. J Med Chem 55(5):1817\u20131830. https:\/\/doi.org\/10.1021\/jm2013248","journal-title":"J Med Chem"},{"issue":"12","key":"10422_CR12","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1517\/13543784.15.12.1507","volume":"15","author":"A Savarino","year":"2006","unstructured":"Savarino A (2006) A historical sketch of the discovery and development of HIV-1 integrase inhibitors. Expert Opin Invest Drugs 15(12):1507\u20131522. https:\/\/doi.org\/10.1517\/13543784.15.12.1507","journal-title":"Expert Opin Invest Drugs"},{"issue":"8","key":"10422_CR13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1358\/dof.2009.34.8.1400202","volume":"34","author":"ND James","year":"2009","unstructured":"James ND, Growcott JW (2009) Zibotentan endothelin ETA receptor antagonist oncolytic. Drugs Future 34(8):624\u2013633. https:\/\/doi.org\/10.1358\/dof.2009.34.8.1400202","journal-title":"Drugs Future"},{"issue":"7","key":"10422_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.7164\/antibiotics.24.443","volume":"24","author":"M Ogata","year":"1971","unstructured":"Ogata M, Atobe H, Kushida H, Yamamoto K (1971) In vitro sensitivity of mycoplasmas isolated from various animals and sewage to antibiotics and nitrofurans. J Antibiotics 24(7):443\u2013451. https:\/\/doi.org\/10.7164\/antibiotics.24.443","journal-title":"J Antibiotics"},{"issue":"3","key":"10422_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/clpt.1983.170","volume":"34","author":"S Vardan","year":"1983","unstructured":"Vardan S, Smulyan H, Mookherjee S, Eich R (1983) Effects of tiodazosin, a new antihypertensive, hemodynamics and clinical variables. Clin Pharmacol Ther 34(3):290\u2013296. https:\/\/doi.org\/10.1038\/clpt.1983.170","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10422_CR16","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.3390\/molecules25081789","volume":"25","author":"J Krzywik","year":"2020","unstructured":"Krzywik J, Mozga W, Aminpour M, Janczak J, Maj E, Wietrzyk J et al (2020) Synthesis, antiproliferative activity and molecular docking studies of novel doubly modified colchicine amides and sulfonamides as anticancer agents. Molecules 25(8):1789. https:\/\/doi.org\/10.3390\/molecules25081789","journal-title":"Molecules"},{"issue":"9","key":"10422_CR17","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1016\/j.ejmech.2011.05.037","volume":"46","author":"NS El-Sayed","year":"2011","unstructured":"El-Sayed NS, El-Bendary ER, El-Ashry SM, El-Kerdawy MM (2011) Synthesis and antitumor activity of new sulfonamide derivatives of thiadiazolo [3, 2-a] pyrimidines. Eur J Med Chem 46(9):3714\u20133720. https:\/\/doi.org\/10.1016\/j.ejmech.2011.05.037","journal-title":"Eur J Med Chem"},{"issue":"12","key":"10422_CR18","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/S0968-0896(03)00179-2","volume":"11","author":"A Johansson","year":"2003","unstructured":"Johansson A, Poliakov A, \u00c5kerblom E, Wiklund K, Lindeberg G, Winiwarter S et al (2003) Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-length NS3 (protease-helicase\/NTPase): a comparative study of different C-terminals. Bioorg Med Chem 11(12):2551\u20132568. https:\/\/doi.org\/10.1016\/S0968-0896(03)00179-2","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"10422_CR19","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s00044-019-02382-w","volume":"28","author":"AM Galal","year":"2019","unstructured":"Galal AM, Fayad W, Mettwally WS, Gomaa SK, Ahmed ER, El-Refai HA et al (2019) Cytotoxicity of multicellular cancer spheroids, antibacterial, and antifungal of selected sulfonamide derivatives coupled with a salicylamide and\/or anisamide scaffold. Med Chem Res 28(9):1425\u20131440. https:\/\/doi.org\/10.1007\/s00044-019-02382-w","journal-title":"Med Chem Res"},{"issue":"12","key":"10422_CR20","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.1016\/j.ejmech.2011.08.015","volume":"46","author":"S Bano","year":"2011","unstructured":"Bano S, Javed K, Ahmad S, Rathish I, Singh S, Alam M (2011) Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents. Eur J Med Chem 46(12):5763\u20135768. https:\/\/doi.org\/10.1016\/j.ejmech.2011.08.015","journal-title":"Eur J Med Chem"},{"key":"10422_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ejmech.2015.01.008","volume":"92","author":"J Li","year":"2015","unstructured":"Li J, Lou J, Wang Z, Wang T, Xiao Y, Xianming H, Liu P, Hong X (2015) Design, synthesis and pharmacological evaluation of novel N-(2-(1, 1-dimethyl-5, 7-dioxo-4, 6-diazaspiro[2.4]heptan-6-yl)ethyl) sulfonamide derivatives as potential anticonvulsant agents. Eur J Med Chem 92:370\u2013376. https:\/\/doi.org\/10.1016\/j.ejmech.2015.01.008","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10422_CR22","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/S0021-9258(18)91799-0","volume":"244","author":"DP Richey","year":"1969","unstructured":"Richey DP, Brown GM (1969) The biosynthesis of folic acid IX. Purification and properties of the enzymes required for the formation of dihydropteroic acid. J Biol Chem 244(6):1582\u20131592","journal-title":"J Biol Chem"},{"issue":"2","key":"10422_CR23","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0021-9258(18)93957-8","volume":"237","author":"GM Brown","year":"1962","unstructured":"Brown GM (1962) The biosynthesis of folic acid. J Biol Chem 237(2):536\u2013540. https:\/\/doi.org\/10.1016\/S0021-9258(18)93957-8","journal-title":"J Biol Chem"},{"issue":"1","key":"10422_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.36468\/pharmaceutical-sciences.629","volume":"82","author":"J Sahoo","year":"2020","unstructured":"Sahoo J, Kshiroda P, Sarangi N, Rout S, Paidesetty S (2020) In silico investigation and biological evaluation of synthesized sulfamethoxazole derivatives. Indian J Pharm Sci 82(1):123\u2013130","journal-title":"Indian J Pharm Sci"},{"key":"10422_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2014.07.052","author":"T Nasr","year":"2014","unstructured":"Nasr T, Bondock S, Eid S (2014) Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2014.07.052","journal-title":"Eur J Med Chem"},{"key":"10422_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2020.114203","author":"Y Lv","year":"2020","unstructured":"Lv Y, Xu J, Xu K, Liu X, Guo X, Lu S et al (2020) Accumulation characteristics and biological response of ginger to sulfamethoxazole and ofloxacin. Environ Pollut. https:\/\/doi.org\/10.1016\/j.envpol.2020.114203","journal-title":"Environ Pollut"},{"issue":"1","key":"10422_CR27","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1080\/14756366.2020.1746784","volume":"35","author":"M Durgun","year":"2020","unstructured":"Durgun M, T\u00fcrke\u015f C, I\u015f\u0131k M, Demir Y, Sakl\u0131 A, Kuru A et al (2020) Synthesis, characterization, biological evaluation and in silico studies of sulfonamide Schiff bases. J Enzyme Inhib Med Chem 35(1):950\u2013962. https:\/\/doi.org\/10.1080\/14756366.2020.1746784","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10422_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1790422","author":"P Taslimi","year":"2020","unstructured":"Taslimi P, I\u015f\u0131k M, T\u00fcrkan F, Durgun M, T\u00fcrke\u015f C, G\u00fcl\u00e7in \u0130 et al (2020) Benzenesulfonamide derivatives as potent acetylcholinesterase, \u03b1-glycosidase, and glutathione S-transferase inhibitors: biological evaluation and molecular docking studies. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1790422","journal-title":"J Biomol Struct Dyn"},{"issue":"12","key":"10422_CR29","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/S0968-0896(98)80022-9","volume":"6","author":"KA Scheidt","year":"1998","unstructured":"Scheidt KA, Roush WR, McKerrow JH, Selzer PM, Hansell E, Rosenthal PJ (1998) Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors. Bioorg Med Chem 6(12):2477\u20132494. https:\/\/doi.org\/10.1016\/S0968-0896(98)80022-9","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"10422_CR30","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3906\/kim-2004-36","volume":"44","author":"C Yamali","year":"2020","unstructured":"Yamali C, G\u00fcl H\u0130, Demir Y, Kazaz C, G\u00fcl\u00e7in \u0130 (2020) Synthesis and bioactivities of 1-(4-hydroxyphenyl)-2-((heteroaryl) thio) ethanones as carbonic anhydrase I, II and acetylcholinesterase inhibitors. Turk J Chem 44(4):1058\u20131067. https:\/\/doi.org\/10.3906\/kim-2004-36","journal-title":"Turk J Chem"},{"issue":"4","key":"10422_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202000958","volume":"18","author":"S Akocak","year":"2021","unstructured":"Akocak S, Taslimi P, Lolak N, I\u015f\u0131k M, Durgun M, Budak Y et al (2021) Synthesis, characterization, and inhibition study of novel substituted phenylureido sulfaguanidine derivatives as \u03b1-glycosidase and cholinesterase inhibitors. Chem Biodivers 18(4):e2000958. https:\/\/doi.org\/10.1002\/cbdv.202000958","journal-title":"Chem Biodivers"},{"issue":"3","key":"10422_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202000282","volume":"354","author":"M Kalayc\u0131","year":"2020","unstructured":"Kalayc\u0131 M, T\u00fcrke\u015f C, Arslan M, Demir Y, Beydemir \u015e (2020) Novel benzoic acid derivatives: synthesis and biological evaluation as multi-target acetylcholinesterase and carbonic anhydrase inhibitors. Arch Pharm 354(3):e2000282. https:\/\/doi.org\/10.1002\/ardp.202000282","journal-title":"Arch Pharm"},{"issue":"5","key":"10422_CR33","doi-asserted-by":"publisher","first-page":"2000330","DOI":"10.1002\/ardp.202000330","volume":"354","author":"BO Aydin","year":"2021","unstructured":"Aydin BO, Anil D, Demir Y (2021) Synthesis of N-alkylated pyrazolo[3,4\u2010d] pyrimidine analogs and evaluation of acetylcholinesterase and carbonic anhydrase inhibition properties. Arch Pharm 354(5):2000330. https:\/\/doi.org\/10.1002\/ardp.202000330","journal-title":"Arch Pharm"},{"key":"10422_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.02.013","author":"F Turkan","year":"2019","unstructured":"Turkan F, \u00c7etin A, Taslimi P, Karaman M, Gul\u00e7in \u0130 (2019) Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors. Bioorg Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2019.02.013","journal-title":"Bioorg Chem"},{"key":"10422_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.09.043","author":"B Sever","year":"2020","unstructured":"Sever B, T\u00fcrke\u015f C, Alt\u0131ntop MD, Demir Y, Beydemir \u015e (2020) Thiazolyl-pyrazoline derivatives: in vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.09.043","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"10422_CR36","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1080\/07391102.2020.1736631","volume":"39","author":"C T\u00fcrke\u015f","year":"2021","unstructured":"T\u00fcrke\u015f C, Demir Y, Beydemir \u015e (2021) Calcium channel blockers: molecular docking and inhibition studies on carbonic anhydrase I and II isoenzymes. J Biomol Struct Dyn 39(5):1672\u20131680. https:\/\/doi.org\/10.1080\/07391102.2020.1736631","journal-title":"J Biomol Struct Dyn"},{"issue":"2","key":"10422_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202000230","volume":"354","author":"M Tugrak","year":"2020","unstructured":"Tugrak M, Gul HI, Demir Y, Gulcin I (2020) Synthesis of benzamide derivatives with thiourea-substituted benzenesulfonamides as carbonic anhydrase inhibitors. Arch Pharm 354(2):e2000230. https:\/\/doi.org\/10.1002\/ardp.202000230","journal-title":"Arch Pharm"},{"issue":"6","key":"10422_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201900383","volume":"353","author":"Q Istrefi","year":"2020","unstructured":"Istrefi Q, T\u00fcrke\u015f C, Arslan M, Demir Y, Nixha AR, Beydemir \u015e et al (2020) Sulfonamides incorporating ketene N,S-acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors. Arch Pharm 353(6):e1900383. https:\/\/doi.org\/10.1002\/ardp.201900383","journal-title":"Arch Pharm"},{"issue":"2","key":"10422_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12956","volume":"29","author":"E Hoff","year":"2020","unstructured":"Hoff E, Zou D, Schiza S, Demir Y, Grote L, Bouloukaki I et al (2020) Carbonic anhydrase, obstructive sleep apnea and hypertension: effects of intervention. J Sleep Res 29(2):e12956. https:\/\/doi.org\/10.1111\/jsr.12956","journal-title":"J Sleep Res"},{"key":"10422_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103004","author":"C T\u00fcrke\u015f","year":"2019","unstructured":"T\u00fcrke\u015f C, Arslan M, Demir Y, Cocaj L, Nixha AR, Beydemir \u015e (2019) Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors. Bioorg Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103004","journal-title":"Bioorg Chem"},{"issue":"1","key":"10422_CR41","doi-asserted-by":"publisher","first-page":"2000243","DOI":"10.1002\/ardp.202000243","volume":"354","author":"S Bilginer","year":"2021","unstructured":"Bilginer S, Gul HI, Anil B, Demir Y, Gulcin I (2021) Synthesis and in silico studies of triazene-substituted sulfamerazine derivatives as acetylcholinesterase and carbonic anhydrases inhibitors. Arch Pharm 354(1):2000243. https:\/\/doi.org\/10.1002\/ardp.202000243","journal-title":"Arch Pharm"},{"issue":"2","key":"10422_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V Jr, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7(2):88\u201395. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10422_CR43","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1080\/10942912.2019.1656234","volume":"22","author":"M Topal","year":"2019","unstructured":"Topal M (2019) The inhibition profile of sesamol against \u03b1-glycosidase and acetylcholinesterase enzymes. Int J Food Prop 22(1):1527\u20131535. https:\/\/doi.org\/10.1080\/10942912.2019.1656234","journal-title":"Int J Food Prop"},{"issue":"10","key":"10422_CR44","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2174\/1570180817999200520123510","volume":"17","author":"C Yamali","year":"2020","unstructured":"Yamali C, Gul HI, Cakir T, Demir Y, Gulcin I (2020) Aminoalkylated phenolic chalcones: investigation of biological effects on acetylcholinesterase and carbonic anhydrase I and II as potential lead enzyme inhibitors. Lett Drug Des Discov 17(10):1283\u20131292. https:\/\/doi.org\/10.2174\/1570180817999200520123510","journal-title":"Lett Drug Des Discov"},{"key":"10422_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105009","author":"S Askin","year":"2021","unstructured":"Askin S, Tahtaci H, T\u00fcrke\u015f C, Demir Y, Ece A, \u00c7ift\u00e7i GA et al (2021) Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo [2, 1-b][1, 3, 4] thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors. Bioorg Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105009","journal-title":"Bioorg Chem"},{"issue":"18","key":"10422_CR46","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1016\/S0021-9258(18)95800-X","volume":"242","author":"JA Verpoorte","year":"1967","unstructured":"Verpoorte JA, Mehta S, Edsall JT (1967) Esterase activities of human carbonic anhydrases B and C. J Biol Chem 242(18):4221\u20134229. https:\/\/doi.org\/10.1016\/S0021-9258(18)95800-X","journal-title":"J Biol Chem"},{"issue":"10","key":"10422_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22385","volume":"33","author":"F Topal","year":"2019","unstructured":"Topal F (2019) Inhibition profiles of voriconazole against acetylcholinesterase, \u03b1-glycosidase, and human carbonic anhydrase I and II isoenzymes. J Biochem Mol Toxicol 33(10):e22385. https:\/\/doi.org\/10.1002\/jbt.22385","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"10422_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22010","volume":"32","author":"C Caglayan","year":"2018","unstructured":"Caglayan C, Gulcin \u0130 (2018) The toxicological effects of some avermectins on goat liver carbonic anhydrase enzyme. J Biochem Mol Toxicol 32(1):e22010. https:\/\/doi.org\/10.1002\/jbt.22010","journal-title":"J Biochem Mol Toxicol"},{"issue":"39","key":"10422_CR49","doi-asserted-by":"publisher","first-page":"8264","DOI":"10.1021\/bi201284u","volume":"50","author":"KA Johnson","year":"2011","unstructured":"Johnson KA, Goody RS (2011) The original Michaelis constant: translation of the 1913 Michaelis\u2013Menten paper. Biochemistry 50(39):8264\u20138269. https:\/\/doi.org\/10.1021\/bi201284u","journal-title":"Biochemistry"},{"issue":"40","key":"10422_CR50","doi-asserted-by":"publisher","first-page":"11137","DOI":"10.1002\/slct.202103100","volume":"6","author":"C T\u00fcrke\u015f","year":"2021","unstructured":"T\u00fcrke\u015f C, Kesebir \u00d6zt\u00fcrk A, Demir Y, K\u00fcfrevio\u011flu \u00d6\u0130, Beydemir \u015e (2021) Calcium channel blockers: the effect of glutathione S-transferase enzyme activity and molecular docking studies. ChemistrySelect 6(40):11137\u201311143. https:\/\/doi.org\/10.1002\/slct.202103100","journal-title":"ChemistrySelect"},{"key":"10422_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21887","author":"FS Tokal\u0131","year":"2021","unstructured":"Tokal\u0131 FS, Demir Y, Demircio\u011flu \u0130H, T\u00fcrke\u015f C, Kalay E, \u015eendil K et al (2021) Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin-4 (3H)-one derivatives as potential aldose reductase inhibitors. Drug Dev Res. https:\/\/doi.org\/10.1002\/ddr.21887","journal-title":"Drug Dev Res"},{"issue":"3","key":"10422_CR52","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1021\/ja01318a036","volume":"56","author":"H Lineweaver","year":"1934","unstructured":"Lineweaver H, Burk D (1934) The determination of enzyme dissociation constants. J Am Chem Soc 56(3):658\u2013666. https:\/\/doi.org\/10.1021\/ja01318a036","journal-title":"J Am Chem Soc"},{"issue":"5","key":"10422_CR53","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/ddr.21667","volume":"81","author":"Y Demir","year":"2020","unstructured":"Demir Y (2020) Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase-1 associated with cardiovascular diseases. Drug Dev Res 81(5):628\u2013636. https:\/\/doi.org\/10.1002\/ddr.21667","journal-title":"Drug Dev Res"},{"issue":"1","key":"10422_CR54","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/bab.2107","volume":"69","author":"B \u00c7al\u0131\u015fkan","year":"2021","unstructured":"\u00c7al\u0131\u015fkan B, Kesebir A\u00d6, Demir Y, Salman \u0130A (2021) The effect of brimonidine and proparacaine on metabolic enzymes: glucose\u20106\u2010phosphate dehydrogenase, 6\u2010phosphogluconate dehydrogenase, and glutathione reductase. Biotechnol Appl Biochem 69(1):281\u2013288. https:\/\/doi.org\/10.1002\/bab.2107","journal-title":"Biotechnol Appl Biochem"},{"issue":"1","key":"10422_CR55","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pharep.2013.08.007","volume":"66","author":"C T\u00fcrke\u015f","year":"2014","unstructured":"T\u00fcrke\u015f C, S\u00f6y\u00fct H, Beydemir \u015e (2014) Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress. Pharmacol Rep 66(1):74\u201380. https:\/\/doi.org\/10.1016\/j.pharep.2013.08.007","journal-title":"Pharmacol Rep"},{"issue":"4","key":"10422_CR56","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3109\/14756366.2014.959511","volume":"30","author":"C T\u00fcrke\u015f","year":"2015","unstructured":"T\u00fcrke\u015f C, S\u00f6y\u00fct H, Beydemir \u015e (2015) Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium. J Enzyme Inhib Med Chem 30(4):622\u2013628. https:\/\/doi.org\/10.3109\/14756366.2014.959511","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10422_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2015.11.024","author":"C T\u00fcrke\u015f","year":"2016","unstructured":"T\u00fcrke\u015f C, S\u00f6y\u00fct H, Beydemir \u015e (2016) In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum. Environ Toxicol Pharmacol. https:\/\/doi.org\/10.1016\/j.etap.2015.11.024","journal-title":"Environ Toxicol Pharmacol"},{"issue":"5","key":"10422_CR58","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3109\/14756366.2012.715287","volume":"28","author":"Y Akbaba","year":"2013","unstructured":"Akbaba Y, T\u00fcrke\u015f C, Polat L, S\u00f6y\u00fct H, \u015eahin E, Menzek A et al (2013) Synthesis and paroxonase activities of novel bromophenols. J Enzyme Inhib Med Chem 28(5):1073\u20131079. https:\/\/doi.org\/10.3109\/14756366.2012.715287","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"10422_CR59","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12010-019-03009-x","volume":"189","author":"C T\u00fcrke\u015f","year":"2019","unstructured":"T\u00fcrke\u015f C, Demir Y, Beydemir \u015e (2019) Anti-diabetic properties of calcium channel blockers: inhibition effects on aldose reductase enzyme activity. Appl Biochem Biotechnol 189(1):318\u2013329. https:\/\/doi.org\/10.1007\/s12010-019-03009-x","journal-title":"Appl Biochem Biotechnol"},{"issue":"10","key":"10422_CR60","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/jphp.13144","volume":"71","author":"Y Demir","year":"2019","unstructured":"Demir Y (2019) The behaviour of some antihypertension drugs on human serum paraoxonase-1: an important protector enzyme against atherosclerosis. J Pharm Pharmacol 71(10):1576\u20131583. https:\/\/doi.org\/10.1111\/jphp.13144","journal-title":"J Pharm Pharmacol"},{"key":"10422_CR61","first-page":"160","volume-title":"Advanced Materials Research","author":"N Hasbullah","year":"2013","unstructured":"Hasbullah N, Mazatulikhma MZ, Kamarulzaman N (2013) Nanotoxicity of magnesium oxide on human neuroblastoma SH-SY5Y cell lines. Advanced Materials Research. Trans Tech Publ, pp 160\u2013164"},{"key":"10422_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.07.026","author":"ME Valencia","year":"2018","unstructured":"Valencia ME, Herrera-Arozamena C, de Andr\u00e9s L, P\u00e9rez C, Morales-Garc\u00eda JA, P\u00e9rez-Castillo A et al (2018) Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer\u2019s disease. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2018.07.026","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10422_CR63","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1007\/s11033-019-04706-w","volume":"46","author":"A Taghizadehghalehjoughi","year":"2019","unstructured":"Taghizadehghalehjoughi A, Sezen S, Hacimuftuoglu A, G\u00fcll\u00fcce M (2019) Vincristine combination with Ca+ 2 channel blocker increase antitumor effects. Mol Biol Rep 46(2):2523\u20132528. https:\/\/doi.org\/10.1007\/s11033-019-04706-w","journal-title":"Mol Biol Rep"},{"issue":"6","key":"10422_CR64","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10616-020-00432-5","volume":"72","author":"MS Ertugrul","year":"2020","unstructured":"Ertugrul MS, Nadaroglu H, Nalci OB, Hacimuftuoglu A, Alayli A (2020) Preparation of CoS nanoparticles-cisplatin bio-conjugates and investigation of their effects on SH-SY5Y neuroblastoma cell line. Cytotechnology 72(6):885\u2013896. https:\/\/doi.org\/10.1007\/s10616-020-00432-5","journal-title":"Cytotechnology"},{"issue":"12","key":"10422_CR65","doi-asserted-by":"publisher","first-page":"9715","DOI":"10.1007\/s11033-020-05987-2","volume":"47","author":"OB Nalci","year":"2020","unstructured":"Nalci OB, Nadaroglu H, Genc S, Hacimuftuoglu A, Alayli A (2020) The effects of MgS nanoparticles-Cisplatin-bio-conjugate on SH-SY5Y neuroblastoma cell line. Mol Biol Rep 47(12):9715\u20139723. https:\/\/doi.org\/10.1007\/s11033-020-05987-2","journal-title":"Mol Biol Rep"},{"issue":"3","key":"10422_CR66","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1021\/acs.jmedchem.9b02067","volume":"63","author":"WC Wright","year":"2020","unstructured":"Wright WC, Chenge J, Wang J, Girvan HM, Yang L, Chai SC et al (2020) Clobetasol propionate is a heme-mediated selective inhibitor of human cytochrome P450 3A5. J Med Chem 63(3):1415\u20131433. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b02067","journal-title":"J Med Chem"},{"issue":"6","key":"10422_CR67","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2174\/0929866526666190226162225","volume":"26","author":"C T\u00fcrke\u015f","year":"2019","unstructured":"T\u00fcrke\u015f C (2019) Investigation of potential paraoxonase-I inhibitors by kinetic and molecular docking studies: chemotherapeutic drugs. Protein Pept Lett 26(6):392\u2013402. https:\/\/doi.org\/10.2174\/0929866526666190226162225","journal-title":"Protein Pept Lett"},{"key":"10422_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2019.09.237","author":"M I\u015f\u0131k","year":"2020","unstructured":"I\u015f\u0131k M, Beydemir \u015e, Demir Y, Durgun M, T\u00fcrke\u015f C, Nas\u0131r A et al (2020) Benzenesulfonamide derivatives containing imine and amine groups: inhibition on human paraoxonase and molecular docking studies. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.09.237","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"10422_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202000102","volume":"353","author":"M I\u015f\u0131k","year":"2020","unstructured":"I\u015f\u0131k M, Akocak S, Lolak N, Taslimi P, T\u00fcrke\u015f C, G\u00fcl\u00e7in \u0130 et al (2020) Synthesis, characterization, biological evaluation, and in silico studies of novel 1,3-diaryltriazene-substituted sulfathiazole derivatives. Arch Pharm 353(9):e2000102. https:\/\/doi.org\/10.1002\/ardp.202000102","journal-title":"Arch Pharm"},{"issue":"1","key":"10422_CR70","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/07391102.2020.1806927","volume":"40","author":"C T\u00fcrke\u015f","year":"2022","unstructured":"T\u00fcrke\u015f C, Demir Y, Beydemir \u015e (2022) Some calcium-channel blockers: kinetic and in silico studies on paraoxonase-I. J Biomol Struct Dyn 40(1):77\u201385. https:\/\/doi.org\/10.1080\/07391102.2020.1806927","journal-title":"J Biomol Struct Dyn"},{"issue":"1\u20133","key":"10422_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23(1\u20133):3\u201325. https:\/\/doi.org\/10.1016\/S0169-409X(96)00423-1","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"10422_CR72","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1021\/ja993663t","volume":"122","author":"EM Duffy","year":"2000","unstructured":"Duffy EM, Jorgensen WL (2000) Prediction of properties from simulations: free energies of solvation in hexadecane, octanol, and water. J Am Chem Soc 122(12):2878\u20132888. https:\/\/doi.org\/10.1021\/ja993663t","journal-title":"J Am Chem Soc"},{"issue":"7","key":"10422_CR73","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","volume":"53","author":"JB Baell","year":"2010","unstructured":"Baell JB, Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53(7):2719\u20132740. https:\/\/doi.org\/10.1021\/jm901137j","journal-title":"J Med Chem"},{"issue":"10","key":"10422_CR74","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/jphp.13141","volume":"71","author":"C T\u00fcrke\u015f","year":"2019","unstructured":"T\u00fcrke\u015f C (2019) A potential risk factor for paraoxonase 1: in silico and in-vitro analysis of the biological activity of proton-pump inhibitors. J Pharm Pharmacol 71(10):1553\u20131564. https:\/\/doi.org\/10.1111\/jphp.13141","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"10422_CR75","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1080\/01480545.2019.1620266","volume":"44","author":"\u015e Beydemir","year":"2021","unstructured":"Beydemir \u015e, T\u00fcrke\u015f C, Yal\u00e7\u0131n A (2021) Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies. Drug Chem Toxicol 44(5):508\u2013517. https:\/\/doi.org\/10.1080\/01480545.2019.1620266","journal-title":"Drug Chem Toxicol"},{"key":"10422_CR76","doi-asserted-by":"publisher","DOI":"10.1007\/s11696-019-00988-3","author":"M I\u015f\u0131k","year":"2020","unstructured":"I\u015f\u0131k M, Demir Y, Durgun M, T\u00fcrke\u015f C, Necip A, Beydemir \u015e (2020) Molecular docking and investigation of 4-(benzylideneamino)-and 4-(benzylamino)-benzenesulfonamide derivatives as potent AChE inhibitors. Chem Pap. https:\/\/doi.org\/10.1007\/s11696-019-00988-3","journal-title":"Chem Pap"},{"key":"10422_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jorganchem.2020.121542","author":"A Kilic","year":"2020","unstructured":"Kilic A, Beyazsakal L, I\u015f\u0131k M, T\u00fcrke\u015f C, Necip A, Tak\u0131m K et al (2020) Mannich reaction derived novel boron complexes with amine-bis(phenolate) ligands: synthesis, spectroscopy and in vitro\/in silico biological studies. J Organomet Chem. https:\/\/doi.org\/10.1016\/j.jorganchem.2020.121542","journal-title":"J Organomet Chem"},{"issue":"45","key":"10422_CR78","doi-asserted-by":"publisher","first-page":"13347","DOI":"10.1002\/slct.201903458","volume":"4","author":"S G\u00fcndo\u011fdu","year":"2019","unstructured":"G\u00fcndo\u011fdu S, T\u00fcrke\u015f C, Arslan M, Demir Y, Beydemir \u015e (2019) New Isoindole-1, 3-dione substituted sulfonamides as potent inhibitors of carbonic anhydrase and acetylcholinesterase: design, synthesis, and biological evaluation. ChemistrySelect 4(45):13347\u201313355. https:\/\/doi.org\/10.1002\/slct.201903458","journal-title":"ChemistrySelect"},{"key":"10422_CR79","doi-asserted-by":"publisher","DOI":"10.1515\/chem-2021-0032","author":"B Sever","year":"2021","unstructured":"Sever B, Alt\u0131ntop MD, Demir Y, T\u00fcrke\u015f C, \u00d6zba\u015f K, \u00c7ift\u00e7i GA et al (2021) A new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activity. Open Chem. https:\/\/doi.org\/10.1515\/chem-2021-0032","journal-title":"Open Chem"},{"issue":"22","key":"10422_CR80","doi-asserted-by":"publisher","first-page":"10282","DOI":"10.1021\/jm300871x","volume":"55","author":"J Cheung","year":"2012","unstructured":"Cheung J, Rudolph MJ, Burshteyn F, Cassidy MS, Gary EN, Love J et al (2012) Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem 55(22):10282\u201310286. https:\/\/doi.org\/10.1021\/jm300871x","journal-title":"J Med Chem"},{"key":"10422_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111600","author":"M Bozdag","year":"2019","unstructured":"Bozdag M, Ferraroni M, Ward C, Carta F, Bua S, Angeli A et al (2019) Carbonic anhydrase inhibitors based on sorafenib scaffold: design, synthesis, crystallographic investigation and effects on primary breast cancer cells. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111600","journal-title":"Eur J Med Chem"},{"issue":"7","key":"10422_CR82","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/cphc.201701104","volume":"19","author":"A Pecina","year":"2018","unstructured":"Pecina A, Brynda J, Vrzal L, Gnanasekaran R, Ho\u0159ej\u0161\u00ed M, Eyrilmez SM et al (2018) Ranking power of the SQM\/COSMO scoring function on carbonic anhydrase II\u2013inhibitor complexes. ChemPhysChem 19(7):873\u2013879. https:\/\/doi.org\/10.1002\/cphc.201701104","journal-title":"ChemPhysChem"},{"issue":"33","key":"10422_CR83","doi-asserted-by":"publisher","first-page":"9731","DOI":"10.1002\/slct.201902424","volume":"4","author":"C T\u00fcrke\u015f","year":"2019","unstructured":"T\u00fcrke\u015f C, Beydemir \u015e, K\u00fcfrevio\u011flu \u00d6\u0130 (2019) In vitro and in silico studies on the toxic effects of antibacterial drugs as human serum paraoxonase 1 inhibitor. ChemistrySelect 4(33):9731\u20139736. https:\/\/doi.org\/10.1002\/slct.201902424","journal-title":"ChemistrySelect"},{"issue":"3","key":"10422_CR84","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput-Aided Mol Des 27(3):221\u2013234. https:\/\/doi.org\/10.1007\/s10822-013-9644-8","journal-title":"J Comput-Aided Mol Des"},{"key":"10422_CR85","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1967195","author":"Y Demir","year":"2021","unstructured":"Demir Y, Ceylan H, T\u00fcrke\u015f C, Beydemir \u015e (2021) Molecular docking and inhibition studies of vulpinic, carnosic and usnic acids on polyol pathway enzymes. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2021.1967195","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"10422_CR86","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12010-019-03073-3","volume":"190","author":"C T\u00fcrke\u015f","year":"2020","unstructured":"T\u00fcrke\u015f C, Beydemir \u015e (2020) Inhibition of human serum paraoxonase-I with antimycotic drugs: in vitro and in silico studies. Appl Biochem Biotechnol 190(1):252\u2013269. https:\/\/doi.org\/10.1007\/s12010-019-03073-3","journal-title":"Appl Biochem Biotechnol"},{"issue":"2","key":"10422_CR87","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1021\/ci800324m","volume":"49","author":"TA Halgren","year":"2009","unstructured":"Halgren TA (2009) Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model 49(2):377\u2013389. https:\/\/doi.org\/10.1021\/ci800324m","journal-title":"J Chem Inf Model"},{"key":"10422_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103897","author":"N Lolak","year":"2020","unstructured":"Lolak N, Akocak S, T\u00fcrke\u015f C, Taslimi P, I\u015f\u0131k M, Beydemir \u015e et al (2020) Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, \u03b1-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs. Bioorg Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103897","journal-title":"Bioorg Chem"},{"issue":"12","key":"10422_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202100294","volume":"354","author":"B Sever","year":"2021","unstructured":"Sever B, T\u00fcrke\u015f C, Alt\u0131ntop MD, Demir Y, \u00c7ift\u00e7i GA, Beydemir \u015e (2021) Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds. Arch Pharm 354(12):e2100294. https:\/\/doi.org\/10.1002\/ardp.202100294","journal-title":"Arch Pharm"},{"issue":"21","key":"10422_CR90","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA et al (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes. J Med Chem 49(21):6177\u20136196. https:\/\/doi.org\/10.1021\/jm051256o","journal-title":"J Med Chem"},{"issue":"7","key":"10422_CR91","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/1871520620666200218110645","volume":"20","author":"Y Demir","year":"2020","unstructured":"Demir Y, T\u00fcrke\u015f C, Beydemir \u015e (2020) Molecular docking studies and inhibition properties of some antineoplastic agents against paraoxonase-I. Anti-Cancer Agents Med Chem 20(7):887\u2013896. https:\/\/doi.org\/10.2174\/1871520620666200218110645","journal-title":"Anti-Cancer Agents Med Chem"},{"issue":"2","key":"10422_CR92","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/07391102.2019.1583606","volume":"38","author":"A Ece","year":"2020","unstructured":"Ece A (2020) Towards more effective acetylcholinesterase inhibitors: a comprehensive modelling study based on human acetylcholinesterase protein\u2013drug complex. J Biomol Struct Dyn 38(2):565\u2013572. https:\/\/doi.org\/10.1080\/07391102.2019.1583606","journal-title":"J Biomol Struct Dyn"},{"issue":"6","key":"10422_CR93","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1021\/ci700271z","volume":"47","author":"G Barreiro","year":"2007","unstructured":"Barreiro G, Guimar\u00e3es CR, Tubert-Brohman I, Lyons TM, Tirado-Rives J, Jorgensen WL (2007) Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB\/SA scoring. J Chem Inf Model 47(6):2416\u20132428. https:\/\/doi.org\/10.1021\/ci700271z","journal-title":"J Chem Inf Model"},{"issue":"6","key":"10422_CR94","doi-asserted-by":"publisher","first-page":"7278","DOI":"10.1002\/slct.202102082","volume":"29","author":"\u00dc Ya\u015far","year":"2021","unstructured":"Ya\u015far \u00dc, G\u00f6n\u00fcl \u0130, T\u00fcrke\u015f C, Demir Y, Beydemir \u015e (2021) Transition-metal complexes of bidentate Schiff-base ligands: in vitro and in silico evaluation as non-classical carbonic anhydrase and potential acetylcholinesterase inhibitors. ChemistrySelect 29(6):7278\u20137284. https:\/\/doi.org\/10.1002\/slct.202102082","journal-title":"ChemistrySelect"},{"key":"10422_CR95","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1916599","author":"C T\u00fcrke\u015f","year":"2021","unstructured":"T\u00fcrke\u015f C, Akocak S, I\u015f\u0131k M, Lolak N, Taslimi P, Durgun M et al (2021) Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and \u03b1-glucosidase inhibitors. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2021.1916599","journal-title":"J Biomol Struct Dyn"},{"issue":"43","key":"10422_CR96","doi-asserted-by":"publisher","first-page":"11915","DOI":"10.1002\/slct.202103197","volume":"6","author":"C T\u00fcrke\u015f","year":"2021","unstructured":"T\u00fcrke\u015f C, Demir Y, Beydemir \u015e (2021) Infection medications: assessment In-vitro glutathione S-transferase inhibition and molecular docking study. ChemistrySelect 6(43):11915\u201311924. https:\/\/doi.org\/10.1002\/slct.202103197","journal-title":"ChemistrySelect"},{"key":"10422_CR97","doi-asserted-by":"publisher","DOI":"10.1002\/bab.2284","author":"B \u00c7al\u0131\u015fkan","year":"2021","unstructured":"\u00c7al\u0131\u015fkan B, Demir Y, T\u00fcrke\u015f C (2021) Ophthalmic drugs: in vitro paraoxonase 1 inhibition and molecular docking studies. Biotechnol Appl Biochem. https:\/\/doi.org\/10.1002\/bab.2284","journal-title":"Biotechnol Appl Biochem"},{"issue":"6","key":"10422_CR98","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.3109\/14756366.2015.1128426","volume":"31","author":"S K\u0131l\u0131caslan","year":"2016","unstructured":"K\u0131l\u0131caslan S, Arslan M, Ruya Z, Bilen \u00c7, Erg\u00fcn A, Gen\u00e7er N et al (2016) Synthesis and evaluation of sulfonamide-bearing thiazole as carbonic anhydrase isoforms hCA I and hCA II. J Enzyme Inhib Med Chem 31(6):1300\u20131305. https:\/\/doi.org\/10.3109\/14756366.2015.1128426","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10422_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112219","author":"V Sharma","year":"2020","unstructured":"Sharma V, Kumar R, Angeli A, Supuran CT, Sharma PK (2020) Tail approach synthesis of novel benzenesulfonamides incorporating 1, 3, 4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112219","journal-title":"Eur J Med Chem"},{"issue":"11","key":"10422_CR100","doi-asserted-by":"publisher","first-page":"17356","DOI":"10.3390\/molecules191117356","volume":"19","author":"K Rutkauskas","year":"2014","unstructured":"Rutkauskas K, Zubrien\u0117 A, Tumosien\u0117 I, Kantminien\u0117 K, Ka\u017eem\u0117kait\u0117 M, Smirnov A et al (2014) 4-amino-substituted benzenesulfonamides as inhibitors of human carbonic anhydrases. Molecules 19(11):17356\u201317380. https:\/\/doi.org\/10.3390\/molecules191117356","journal-title":"Molecules"},{"issue":"8","key":"10422_CR101","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3760\/cma.j.issn.0366-6999.2010.08.021","volume":"123","author":"H-r Xie","year":"2010","unstructured":"Xie H-r, Hu L-s, Li G-y (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson\u2019s disease. Chinese Med J 123(8):1086\u20131092. https:\/\/doi.org\/10.3760\/cma.j.issn.0366-6999.2010.08.021","journal-title":"Chinese Med J"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10422-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-022-10422-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10422-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T11:02:45Z","timestamp":1744196565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-022-10422-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10422"],"URL":"https:\/\/doi.org\/10.1007\/s11030-022-10422-8","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,9]]},"assertion":[{"value":"3 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}